NEURACEQ

Florbetaben F 18 · Lantheus Biosciences Ltd.

Drug timelines are a Plus or Pro feature.

21 regulatory and trial events tracked for NEURACEQ, covering 2014-03-19 to 2026-08-06. Get the full timeline:

Most recent: EMA Authorised: Neuraceq (florbetaben (18F)) — Lantheus Germany GmbH